文献检索

查找使用阿拉丁产品的科研文献

检索与阿拉丁产品相关的同行评审论文、DOI、PubMed 编号、期刊、作者、CAS 号及研究领域。

科研影响力快照

与阿拉丁产品相关的已发表科研成果

在搜索之前,这些指标可帮助访客快速了解产品关联科研的规模与质量。

347,389+ SCI 论文 与阿拉丁产品引用相关
2,303,681.05 总影响因子 匹配文献记录中影响因子的总和
81.20 最高期刊影响因子 匹配期刊中的最高 IF
6.63 平均期刊影响因子 匹配文献的平均 IF

参考指标 指标基于阿拉丁文献引用数据库及期刊影响因子记录。文献关联仅供科研参考,请以原始文献为准。

产品列表

视图 列表 网格

显示第2845至2856个,产品总数347,389个

切换升序
Molecular Medicine Reports · 2026 ·Vol. 33 ·期 5 ·1-18 · IF 5

Advances regarding physiological functions and mechanisms of theaflavin‑3,3'‑digallate (Review)

Teng Ma,Siwei Zhang,Miaomiao Xiao,Zhijian Ma,Junhong Guan

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

✓ 已验证 DOI 高影响因子
查看原文 查看 PubMed
PHYTOMEDICINE · 2026 · IF 11.3

JianPi QingRe HuoXue Formula targets Cadherin-17 to induce apoptosis in chronic atrophic gastritis with intestinal metaplasia

Zihan Mai,Yiyuan Zheng,Jiali Xie,Yi Wen,Shuye Wang,Yuancheng Huang,Haojie Tan,Jingming Chen,Changlong Wang,Yang Tao,Qiuming Chen,Fengbin Liu,Yimin Liang,Xu Chen,Yingpan Zhao,Peiwu Li,Zehong Yang

Background Chronic atrophic gastritis (CAG) with intestinal metaplasia (IM) constitutes a critical intermediate stage in the progression from chronic non-atrophic gastritis (CNAG) to intestinal-type gastric cancer (GC), for which effective therapeutic strategies remain unavailable. JianPi QingRe HuoXue Formula (JQHF), an empirical prescription of traditional Chinese medicine (TCM), has been widely applied in the clinical management of CAG with IM; however, its underlying mechanisms of action remain incompletely elucidated. Purpose This study aims to evaluate the therapeutic efficacy of JQHF in the treatment of CAG with IM and to clarify its mechanism. Methods The main components of JQHF were identified by UPLC-MS/MS, and its potential pharmacological effects were investigated via network pharmacology. The therapeutic efficacy of JQHF were evaluated in clinical patients, animal models, and cell models, followed by validation of the key pathways and targets. Differentially expressed genes (DEGs) between IM and CNAG were identified from the GEO database and further validated by IHC across the CNAG - CAG - IM. Molecular docking and molecular dynamics simulations were performed to characterize the interactions between the main components of JQHF and CDH17. In addition, patient samples collected before and after JQHF treatment, as well as a CDH17-knockdown mouse model established via tail vein injection of adeno-associated virus (AAV), were used to verify changes in CDH17 expression and to elucidate its potential mechanism of action. Results UPLC-MS/MS identified 21 main components of JQHF. Network pharmacology suggested JQHF is involved in the regulation of apoptosis and the Notch pathway. Clinical evaluation demonstrated that JQHF significantly improved gastric mucosal pathological changes in CAG with IM patients, without causing significant adverse effects. Both in vivo and in vitro experiments demonstrated JQHF effectively alleviated the severity of CAG with IM by inhibiting the Notch pathway and inducing apoptosis. Bioinformatic analysis of GEO database revealed CDH17 expression was significantly elevated in IM compared to CNAG, which was further confirmed by IHC across different disease stages. Molecular docking and dynamics simulations demonstrated favorable binding affinities between the main components of JQHF and CDH17, with Astragaloside IV exhibiting the strongest binding affinity. Furthermore, JQHF treatment suppressed CDH17 expression in gastric mucosal samples from patients, concomitantly inhibited the Notch pathway, and promoted apoptosis. These mechanisms were further validated using a CDH17-knockdown mouse model. Notably, CDH17 gene knockdown also attenuated the therapeutic efficacy of JQHF, suggesting CDH17 plays a critical role in mediating the pharmacological effects of JQHF. Conclusions JQHF exerts a positive therapeutic effect on CAG with IM without causing significant adverse effects. Its mechanism of action appears to involve targeting CDH17 to modulate the Notch pathway and induce apoptosis.

CAS / MDL: 684-93-5
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
FASEB JOURNAL · 2026 ·Vol. 40 ·期 5 ·e71641 · IF 4.3

Imperatorin Mitigates Rosacea‐Like Inflammation by Modulating the Crosstalk Between JNK1 and STAT1

Xiaoxue Wang,Zexin Zhu

Rosacea is a chronic inflammatory dermatological disorder involving the activation of various signaling pathways. Imperatorin (IMP), a coumarin compound, has been documented to exhibit anti‐inflammatory properties. Nevertheless, its therapeutic efficacy in managing rosacea remains unexplored. Bioinformatics and network pharmacology approaches were utilized to elucidate potential signaling pathways and molecular targets of IMP in the context of rosacea. Subsequently, to assess the in vivo therapeutic efficacy of IMP, murine models exhibiting rosacea‐like inflammatory responses were developed. Additionally, in vitro experiments were conducted to elucidate the molecular mechanisms underlying the anti‐rosacea effects of IMP. Our findings demonstrated that both intraperitoneal and topical administration of IMP significantly attenuated skin inflammation in mice with LL37‐induced rosacea models. Mechanistic investigations, guided by bioinformatics and network pharmacology analyses, revealed an interaction between JNK1 and STAT1. IMP was found to directly bind to JNK1 and STAT1, disrupting their interaction, thereby inhibiting STAT1 phosphorylation and nuclear translocation. This inhibition resulted in decreased production of STAT1‐mediated inflammatory mediators in keratinocytes. These results suggest that IMP may serve as a promising therapeutic agent for inflammatory skin diseases by targeting the crosstalk between JNK1 and STAT1. IMP treatment disrupts the interaction between JNK1 and STAT1, thereby attenuating STAT1 activity. This interference subsequently diminishes the phosphorylation and nuclear translocation of STAT1, which ultimately results in a reduced production of inflammatory cytokines and chemokines. Consequently, this process alleviates the symptoms of rosacea.

CAS / MDL: 482-44-0
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES · 2026 · IF 2.5

Simultaneous quantification of sphingolipid metabolites in human plasma using UPLC-MS/MS

Peiqi Sun,Fei Hang,Jiayang Wang,Yuanye Jiang,Lingyun Pan,Cheng Hu

Sphingosine (SP), dihydro-sphingosine (DSP), and sphingosine 1-phosphate (S1P) are integral metabolites in the sphingolipid pathway. They exhibit intricate and diverse functions in the development of metabolic-associated fatty liver disease (MAFLD). In this study, we developed a highly sensitive and specific analytical approach for the concurrent quantification of these three sphingolipids in human plasma, utilizing ultra-high-performance liquid chromatography (UPLC), in conjunction with tandem mass spectrometry (MS/MS). A stripped biological matrix was generated through optimized activated‑carbon treatment to facilitate more accurate calibration. The sample preparation involved a straightforward protein precipitation method using methanol, followed by concentrating the supernatant and reconstituting it prior to injection. Detection was executed in the multiple reaction monitoring mode with a triple quadrupole mass spectrometer. The chromatographic separation was achieved on a Waters ACQUITY UPLC HSS C 18 column employing gradient elution. D-erythro-sphingosine-d 7 served as the internal standard. The newly established method conformed to recognized standards for selectivity, linearity, accuracy, precision, recovery, matrix effects, and stability. This technique was effectively applied to quantify the three sphingolipid metabolites in plasma samples collected from patients diagnosed with MAFLD ( n  = 30), and healthy controls (n = 30). Analysis of the data revealed significant differences between the groups, with the levels of SP, DSP, and S1P considerably elevated in MAFLD patients compared to healthy subjects.

CAS / MDL: 123-78-4
✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
FREE RADICAL BIOLOGY AND MEDICINE · 2026 · IF 8

METTL14/m6A/CEBPD Axis: A Critical Player in Chronic Cerebral Hypoperfusion–Associated Neuroinflammation

Huanhuan Wang,Hanshu Zhao,Jiadi Gao,Sihan Liu,Yuanqi Xu,Xinyue Zhao,Shanshan Yang,Baozhi Gang,Zhongling Zhang

Vascular dementia (VaD) is a major cause of cognitive decline in the elderly, with chronic cerebral hypoperfusion (CCH) as its core pathogeny linked to neuroinflammation. Microglial M1 polarization drives CCH-related neuroinflammation, but its epigenetic regulation remains unclear. N6-methyladenosine (m6A) modification, centered on methyltransferase-like 14 (METTL14), is abundant in the brain, while CCAAT enhancer binding protein delta (CEBPD) is associated with central nervous system inflammation. This study explored METTL14’s role in microglial polarization and CCH pathology. In vitro , HMC3 cells induced by LPS/TNF-α (10 μg/mL, 50 ng/mL) showed upregulated METTL14 and CEBPD. METTL14 knockdown via short hairpin RNA inhibited the expression of M1 phenotypic markers (iNOS, CD86), reduced the release of pro-inflammatory factors (IL-1β, IL-6), and blocked NF-κB nuclear translocation, indicating that METTL14 silencing suppresses LPS/TNF-α-induced microglial M1 polarization and inflammatory response. In bilateral common carotid artery occlusion (BCCAo)-induced CCH rats, hippocampal METTL14/CEBPD was elevated. Adeno-associated virus-mediated METTL14 knockdown not only attenuated neuroinflammation and neuronal apoptosis in hippocampal CA1, but also significantly improved spatial learning memory and object recognition ability. Mechanistically, RIP-PCR and MeRIP-qPCR confirmed METTL14 enhances CEBPD mRNA stability via m6A modification. CEBPD overexpression reversed METTL14 knockdown’s effect, identifying it as a key downstream mediator. In conclusion, METTL14 knockdown impairs CEBPD mRNA stability via m6A, inhibits TLR4/MyD88/NF-κB pathway and microglial M1 polarization, alleviating CCH-related neuroinflammation and cognitive impairment, providing a potential epigenetic target for VaD.

CAS / MDL: 28718-90-3 50-76-0
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
Acta Pharmaceutica Sinica B · 2026 · IF 14.6

Biomimetic liposomes synergize with high-intensity focused ultrasound to induce ferroptosis in tumors

Ruizhe Xu,Xuejing Li,Xiaomin Su,Xifeng Qin,Ying He,Siyu Wang,Yue Liu,Jiayi Wu,Ting Wang,Mingyang Liu,Boshu Ouyang,Jia Li,Wuli Yang,Bo Zhang,Zhiqing Pang

The efficient targeted delivery and on-demand release of nanomedicines still present significant challenges in tumor therapy. In the present study, we developed a novel strategy of tumor ferroptosis therapy through the synergistic effect of nanomedicines (biomimetic liposomes) and a medical device (high-intensity focused ultrasound, HIFU). It was found that HIFU irradiation induced heightened expressions of CD44 and reactive oxygen species (ROS) in tumor cells by 1.43-fold and 2.64-fold, respectively. This allowed the gambogic acid-loaded, platelet-mimicking liposomes (PLip) to more precisely target the tumor cells through the interaction of CD44 and P-selectin on the PLip and subsequently ROS-responsively release the drug from PLip, thus effectively killing tumor cells. Crucially, gambogic acid also significantly enhanced ROS production, leading to lipid peroxidation and augmented ferroptosis induced by HIFU. In summary, HIFU demonstrates immense potential in synergizing with nanomedicines to combat tumors.

CAS / MDL: 2752-65-0
✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
CELL · 2026 · IF 45.1

Editing strigolactone hormone receptor for robust antiviral silencing in rice

Guoyi Yang,Ming Wu,Shuai Zhang,Yucen Huang,Yixiao Liu,Xiyuan Yu,Jiayang Hu,Le Mi,Peng Gan,Yuansheng Wu,Jing Zou,Baogang Zhang,Qun Hu,Jie Hu,Ruifeng Yao,Bojian Zhong,Xianbo Huang,Huiting Xie,Yinghua Ji,Yi Li,Jie Zhang,Liming Yan,Shou-wei Ding,Shanshan Zhao,Jianguo Wu

The small interfering RNA (siRNA) pathway directs broad-spectrum antiviral defense through RNA silencing so that virulent infection requires efficient suppression of the defense mechanism. Here, we show that strigolactone (SL) hormone signaling promotes antiviral silencing in rice plants by transcriptional activation of RNA-dependent RNA polymerase 1 ( RDR1 ) and RDR6 . We demonstrate that protein P3 of the rice grassy stunt virus (RGSV) blocks SL signaling by directly sequestering the receptor DWARF14 from DWARF3. Structural and functional analyses of the P3-DWARF14 complex reveal that the aspartic acid at position 102 (D102) of DWARF14 is essential for the P3 interaction but not for SL perception. Notably, a single D102N substitution of DWARF14, introduced into two rice cultivars by cytosine base editing (CBE) confers resistance against RGSV by blocking viral suppression of SL signaling-dependent antiviral silencing. Our findings establish a transgene-free strategy for engineering disease resistance by precise genome editing of the SL receptor to escape pathogen suppression of the endogenous defense pathway.

CAS / MDL: 67-68-5
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
NEURON · 2026 · IF 16.9

A bone-derived hormone permits rapid visual escape via GPR37 receptor in a subpopulation of VTA GABAergic neurons

Xuemei Liu,Shuaiyu Wang,Juan Lai,Xiang Gao,Lina Wang,Bo Feng,Liang Yang,Zhengjiang Qian,Ruotian Jiang,Jun Chu,Liming Tan,Xiang Li,Liping Wang

Rapid escape from visual threats is essential for survival, yet the mechanisms establishing its “permissive state” remain poorly understood. Here, we demonstrate that osteocalcin (OCN), a bone-derived hormone, permits rapid visual escape by enhancing the excitability of a ventral tegmental area (VTA) GABAergic neuron subpopulation through the OCN-G Protein-Coupled Receptor 37 (GPR37)-cAMP-TWIK-related halothane-inhibited potassium channel (THIK-1) pathway. Loss of OCN, loss of its receptor GPR37, or conditional deletion of GPR37 in VTA GABAergic or glutamatergic neurons delays escape responses, while reconstituting OCN-GPR37 signaling in the VTA restores normal behavior. Single-cell transcriptomics and electrophysiology reveal that OCN suppresses THIK-1 potassium currents via GPR37-mediated cyclic AMP (cAMP) reduction, thereby increasing neuronal excitability. These findings reveal a novel mechanism through which a bone-derived hormone modulates the excitability of co-releasing neurons to facilitate rapid escape, offering new insights into the regulation of survival behaviors by the bone-brain metabolic axis.

CAS / MDL: 10108-64-2
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
Cell Metabolism · 2026 · IF 37

Compartmentalized branched-chain amino acid metabolism orchestrates colorectal cancer dissemination via an UMP-vimentin axis

Fenfen Ji,Pingmei Huang,Qiming Zhou,Lok Hin Ko,Qinyao Wei,Charis Cheuk-Lok Chan,Danyu Chen,Huarong Chen,Wei Kang,Alvin Ho-Kwan Cheung,Cillian H. Cheng,Jianming Shen,Yasi Pan,Ying Jiao,Lin Zhu,Tat Wai Chik,Peisi Xie,Xiao Liang,Onno Kranenburg,Zongwei Cai,Jun Yu,Chi Chun Wong

The role of metabolic compartmentalization in cancer metastasis is unexplored. Here, we identified that compartmentalized branched-chain amino acid (BCAA) metabolism modulates colorectal cancer (CRC) metastasis. Cytosolic BCAA transaminase (BCAT1) promotes epithelial-to-mesenchymal transition (EMT) and cancer spread of CRC cells, whereas the mitochondrial isoform (BCAT2) exerted opposite effects. The location of BCAT is critical, as mitochondria-targeted BCAT1 and cytosolic BCAT2 demonstrated opposite functions in EMT and cell migration, compared with their wild-type counterparts. Mechanistically, cytosolic BCAT promotes nitrogen flux from BCAA to glutamate, aspartate, and uridine monophosphate (UMP), whereas mitochondrial BCAT activity diverts nitrogen flux via glutamate dehydrogenase (GDH) to give NH 3 . UMP binds to vimentin and protects it against ubiquitination-proteasome degradation. Dietary BCAA restriction or blockade of UMP biosynthesis impaired cancer spread of BCAT1-high CRC, and BCAT1-to-BCAT2 expression ratio is an independent prognostic factor in CRC and pan-cancer cohorts, highlighting translational relevance of BCAA metabolic compartmentalization in cancer metastasis.

CAS / MDL: 75706-12-6
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
Cell Host & Microbe · 2026 · IF 23.2

Bacterial entrapment of a fungal carbon repressor prevents plant colonization

Daiying Xu,Aliang Xia,Ruijie Huang,Yongqing Huang,Binsen Zhao,Qifang Shen,Guanghui Wang,Qinhu Wang,Huiquan Liu,Lili Huang,Jin-Rong Xu,Cong Jiang

Carbon catabolite repression (CCR) acts as a switch, reprogramming nutrient utilization in fungal pathogens during the growth-to-colonization transition. However, whether this regulatory system can be exploited by other microbes remains unknown. Here, we demonstrate that Pseudomonas CXZ-8 attenuates the virulence of Fusarium graminearum by hijacking fungal CCR. CXZ-8 disrupts the infection-induced nuclear-to-cytoplasmic relocalization of the CCR master regulator FgCreA, thereby suppressing FCO1 expression, which is crucial for both host cell wall degradation and nutrient acquisition. This interference also benefits the bacterium by preventing the accumulation of host-derived indole derivatives and fungal mycotoxins that threaten its survival. Notably, approximately 20% of field-isolated bacteria exhibit similar FgCreA-stabilizing activity. Furthermore, we assembled a microbial consortium enriched for CCR-targeting bacteria, which conferred broad-spectrum disease resistance in field trials. These findings reveal a novel mode of interkingdom interference and establish CCR as a conserved microbial vulnerability, with implications for sustainable, microbiome-based crop protection.

✓ 已验证 DOI PubMed 高影响因子
查看原文 查看 PubMed
Biomolecules · 2026 ·Vol. 16 ·期 3 ·387 · IF 5.6

Multi-Target Photoprotection by Taxifolin Against UVB-Induced Keratinocyte Injury Through UVB Filtration, ROS Scavenging and Transcriptomic-Proteomic Reprogramming

Fangfang Chen,Yihan Cai,Jinxiong Wu,Nengzhen Fang,Fei Li,Hongtan Wu,Yu-Pei Chen

Taxifolin, a natural flavonoid, consistently exerts cytoprotective effects against various oxidative stresses. In this study, we systematically evaluated its photoprotective efficacy and underlying mechanisms against ultraviolet B (UVB)-induced injury in human immortalized keratinocytes (HaCaT). Cell viability and apoptosis were assessed by MTT, fluorescence staining, and flow cytometry, while integrative transcriptomic and proteomic analyses were employed to identify core pathways and key mediators. Taxifolin exhibited antioxidant capacity comparable to that of ascorbic acid under identical in vitro radical-scavenging assays. Moreover, it displayed a strong absorption peak at 289 nm that overlaps the UVB spectrum (280–320 nm), enabling it to act as a chemical sunscreen. In UVB-challenged HaCaT cells, taxifolin markedly reduced intracellular reactive oxygen species (ROS) and attenuated JNK/p38 MAPK activation, as evidenced by Western blot, thereby breaking the ROS-MAPK vicious cycle. Multi-omics revealed that taxifolin was associated with attenuation of UVB-imposed G1/S arrest concomitant with restored Cyclin expression, while up-regulating MYC, FOXQ1, HMOX1 and AP-1 components c-Jun/c-Fos and thereby switching on a pro-survival transcriptional program. Consequently, apoptosis was suppressed and survival was significantly improved. Collectively, taxifolin integrated chemical filtration, ROS scavenging and signaling modulation to support a multi-target photoprotective network, which provides mechanistic insight into taxifolin-mediated cytoprotection and identifies candidate molecular nodes for further validation.

CAS / MDL: 480-18-2
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
iScience · 2026 · IF 4.5

Low-dose biochar and nitrogen fertilizer reduces nitrogen loss in acidic tea soils

Cenwei Liu,Jing Ye,Yi Lin,Bangwei Zhang,Weixi Shu,Yixiang Wang

Excessive nitrogen fertilizer in red-soil tea plantations reduces quality and yield in southern China and causes environmental issues. This study employed 15 N isotope tracing to evaluate the effects of co-applying biochar (0%, 1%, 2%, and 4%) with nitrogen fertilizer on tea growth, nitrogen use efficiency (NUE), and soil microbial communities in acidic red-soil plantations. The application of 1–2% biochar showed positive outcomes, including increased tea biomass, reduced fertilizer residue and loss, and enhanced soil microbial diversity. In contrast, a high dose of biochar (4%) decreased NUE in whole plants. This reduction was accompanied by an 82.1% increase in urease activity and a 49.5% decrease in nitrate reductase activity. Our findings suggest that co-applying 1–2% biochar with nitrogen represents a promising strategy to optimize root nitrogen uptake, improve tea biomass, and regulate soil microbial communities, thereby supporting more sustainable nitrogen management in tea plantations.

CAS / MDL: 2067-80-3
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
已复制

文献关联基于可获得的产品、CAS、DOI 及引用记录。收录不代表作者或出版方对阿拉丁产品的背书,请以原始文献为准。